Latest Insider Transactions at Koru Medical Systems, Inc. (KRMD)
This section provides a real-time view of insider transactions for Koru Medical Systems, Inc. (KRMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of KORU Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of KORU Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2025
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,870
+6.57%
|
$11,740
$2.56 P/Share
|
|
Apr 02
2025
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,870
+14.88%
|
$11,740
$2.56 P/Share
|
|
Apr 02
2025
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,870
+6.8%
|
$11,740
$2.56 P/Share
|
|
Apr 02
2025
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,806
+4.11%
|
$17,612
$2.56 P/Share
|
|
Apr 02
2025
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,870
+6.77%
|
$11,740
$2.56 P/Share
|
|
Mar 31
2025
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,870
+0.1%
|
-
|
|
Mar 19
2025
|
Linda M Tharby Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,813
-2.77%
|
$59,626
$2.83 P/Share
|
|
Mar 19
2025
|
Christopher Pazdan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,849
-15.21%
|
$25,698
$2.83 P/Share
|
|
Mar 19
2025
|
Christopher Pazdan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,331
+30.07%
|
-
|
|
Mar 17
2025
|
Linda M Tharby Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,848
-0.82%
|
$17,696
$2.89 P/Share
|
|
Mar 17
2025
|
Linda M Tharby Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,968
+1.45%
|
-
|
|
Mar 17
2025
|
Thomas Edward Adams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-36.79%
|
$3,976
$2.89 P/Share
|
|
Mar 17
2025
|
Thomas Edward Adams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,404
+50.0%
|
-
|
|
Mar 17
2025
|
Kenneth E Miller Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,168
-36.79%
|
$4,336
$2.89 P/Share
|
|
Mar 17
2025
|
Kenneth E Miller Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,893
+50.0%
|
-
|
|
Mar 17
2025
|
Christopher Pazdan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,641
-3.3%
|
$3,282
$2.89 P/Share
|
|
Mar 17
2025
|
Christopher Pazdan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+9.23%
|
-
|
|
Feb 06
2025
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
16,187
-0.27%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
BUY
Other acquisition or disposition
|
Direct |
351,948
+40.49%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
2,000,000
-57.26%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
BUY
Other acquisition or disposition
|
Indirect |
1,000,000
+50.0%
|
-
|
|
Jan 03
2025
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,905
+2.91%
|
$17,715
$3.81 P/Share
|
|
Jan 03
2025
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+4.99%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+5.02%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+12.44%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+4.83%
|
$11,811
$3.81 P/Share
|
|
Dec 31
2024
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,937
+0.06%
|
-
|
|
Oct 01
2024
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,454
+7.14%
|
$10,908
$2.75 P/Share
|
|
Oct 01
2024
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,454
+6.9%
|
$10,908
$2.75 P/Share
|
|
Oct 01
2024
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,454
+18.66%
|
$10,908
$2.75 P/Share
|
|
Oct 01
2024
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,454
+7.14%
|
$10,908
$2.75 P/Share
|
|
Oct 01
2024
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,181
+4.11%
|
$16,362
$2.75 P/Share
|
|
Sep 30
2024
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,454
+0.08%
|
-
|
|
Jul 24
2024
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
721,781
-9.5%
|
-
|
|
Jul 11
2024
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,545
+0.07%
|
-
|
|
Jul 11
2024
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,545
+7.8%
|
$11,090
$2.71 P/Share
|
|
Jul 11
2024
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,371
+4.38%
|
$16,742
$2.71 P/Share
|
|
Jul 11
2024
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,545
+7.8%
|
$11,090
$2.71 P/Share
|
|
Jul 11
2024
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,545
+7.52%
|
$11,090
$2.71 P/Share
|
|
Jul 11
2024
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,545
+23.23%
|
$11,090
$2.71 P/Share
|
|
Mar 31
2024
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
6,329
+0.08%
|
-
|
|
Mar 31
2024
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,493
+5.16%
|
$18,986
$2.37 P/Share
|
|
Mar 31
2024
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,329
+9.54%
|
$12,658
$2.37 P/Share
|
|
Mar 31
2024
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,329
+9.18%
|
$12,658
$2.37 P/Share
|
|
Mar 31
2024
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,329
+33.13%
|
$12,658
$2.37 P/Share
|
|
Mar 31
2024
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,329
+9.6%
|
$12,658
$2.37 P/Share
|
|
Mar 13
2024
|
Linda M Tharby Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,094
-0.66%
|
$14,188
$2.09 P/Share
|
|
Mar 13
2024
|
Linda M Tharby Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,681
+1.8%
|
$39,362
$2.09 P/Share
|
|
Feb 16
2024
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
27,700
-0.36%
|
-
|
|
Jan 10
2024
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
453,231
-100.0%
|
-
|